尺寸可变的超分子纳米药物使回氧失衡放大和胆固醇调节能够促进多维瘤免疫疗法
Qi Zhang1, Lingfeng Meng2, Zilin Wang3
1School of Pharmacy, Hebei Province Key Laboratory of Innovative Drug Research and Evaluation, Hebei Medical University, Shijiazhuang, China.
Small (Weinheim an der Bergstrasse, Germany)
|February 17, 2026
概括
工程纳米药物通过诱导铁和免疫记忆来克服瘤免疫抑制和T细胞疲劳. 这种多维策略增强了癌症免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
背景情况:
- 低瘤免疫性和免疫抑制性瘤微环境 (TME) 阻碍了有效的癌症免疫治疗.
- 铁亡诱导显示增强瘤免疫性和T细胞招募的承诺,但受到胆固醇驱动的T细胞耗尽的限制.
研究的目的:
- 为了设计瘤向,TME响应,尺寸可切换的超分子纳米药物用于多维免疫激活.
- 通过克服TME免疫抑制和T细胞枯竭来应对癌症免疫疗法的挑战.
主要方法:
- 开发了尺寸可切换的纳米药物,通过氨/胆固醇暴露深入瘤透.
- 利用氧化,铁和RRx-001的协同作用来诱导氧化还原失衡和铁.
- 促进免疫细胞死亡 (ferroptosis-apoptosis) 来启动抗瘤免疫力.
- 通过消耗胆固醇和降低TME中的PD-1/TIM-3调节来强化T细胞功能.
主要成果:
- 实现了主要和远程瘤生长的显著抑制.
- 建立了持久的免疫记忆,防止瘤复发.
- 通过综合治疗机制系统增强抗瘤免疫力.
结论:
- 工程纳米药物为癌症免疫治疗提供了一个变革性的多维策略.
- 这种方法同时针对瘤免疫性,TME免疫抑制和T细胞枯竭.
- 证明了克服当前免疫治疗方法的关键局限性的潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
25
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
25
Site-Targeted Drug Delivery Systems: Polymeric Carriers
31
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
31
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K


